Zydus Cadila unveils ‘Tenglyn’ tablet

20 Nov 2015 Evaluate

Zydus Cadila has launched ‘Tenglyn’ -- Teneligliptin 20 mg tablets, which belongs to a new class of oral anti-diabetic agents, Gliptins. Tenglyn tablet is one of the most affordable tablets for diabetic patients and is being priced at just Rs. 7 per tablet which is almost 1/6th the price at which the Gliptins were initially launched in India.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. It is the only Indian pharma company to launch its own patented NCE - Lipaglyn, the world’s first drug to be approved for the treatment of diabetic dyslipidemia.

Zydus Lifesciences Share Price

923.70 3.80 (0.41%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×